Clinical Trial Update: Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 data on the efficacy and safety of belimumab in neuromyelitis optica spectrum disorder. The study status is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: NMO Spectrum Disorder | Phase 1, Phase 2 | Status: COMPLETED